Search

Your search keyword '"Marcq, Gautier"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Marcq, Gautier" Remove constraint Author: "Marcq, Gautier"
194 results on '"Marcq, Gautier"'

Search Results

3. Patients non répondeurs au BCG

4. Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer

5. Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis

9. ENLIGHTED phase 3 study: Efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) for treatment of low-grade upper tract urothelial cancer (LG UTUC).

11. PD30-06 PHOTODYNAMIC DIAGNOSIS (PDD) DIRECTED BIOPSIES VS WHITE LIGHT BLADDER MAPPING IN PATIENTS WITH POSITIVE CYTOLOGY AND NEGATIVE PREOPERATIVE WORKUP: AN INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY

12. MP35-11 LONG-TERM ONCOLOGICAL OUTCOMES OF DE NOVO BLADDER CANCER IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS FROM A LARGE MULTICENTER INTERNATIONAL COHORT

13. PD34-12 THE OPTIMAL NUMBER OF INDUCTION CHEMOTHERAPY CYCLES IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER

14. Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review

15. Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study

18. Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study

20. The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer.

21. Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer

24. Practice patterns and survival outcomes for muscle-invasive bladder cancer: real-life experience in a general population setting.

27. Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial

28. MP32-11 FACTORS THAT PREDICT EARLY SALVAGE CYSTECTOMY POST-TRIMODAL THERAPY: RESULTS OF A MULTI-INSTITUTIONAL CANADIAN COHORT

29. PD09-02 THE IMPACT OF VARIANT HISTOLOGY ON CLINICAL OUTCOMES AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

30. MP63-17 PHOTODYNAMIC DIAGNOSIS (PDD) DIRECTED BIOPSIES VS WHITE LIGHT BLADDER MAPPING IN PATIENTS WITH POSITIVE CYTOLOGY AND NEGATIVE PREOPERATIVE WORKUP: AN INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY

31. PD44-08 BENEFIT OF WHOLE-PELVIS RADIATION FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS

32. PD44-02 EFFECT OF GENDER ON SURVIVAL OUTCOMES AFTER TRIMODAL THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

35. Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis

36. Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment-weighted analysis.

37. Study protocol: transurethral REsection and Single instillation intravesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT). A multi-centre international observational study with embedded cluster randomised trial of audit, feedback and education. (Preprint)

41. Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group

42. Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators

44. Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy

46. Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators.

48. MP23-04 BENEFIT OF NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADIATION-BASED THERAPY: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS

49. Reply by Authors

Catalog

Books, media, physical & digital resources